BMG and Concord Combine to Create World’s Leading Independent Music Company
28.4.2026 15:11:00 EEST | Business Wire | Press release
BMG and Concord today announced a definitive agreement to combine their businesses, creating the leading independent music company in the world. Operating under the BMG name, the combined company will bring together two highly complementary businesses to establish a scaled, global company delivering superior service to artists, songwriters, and partners – firmly grounded in an independent, artist-first model.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427537841/en/
Thomas Coesfeld and Bob Valentine, Courtesy of BMG and Concord
The combination comes amid significant transformation in the global music market, where scale, global reach, and technology investment are increasingly critical to remain competitive. Together, BMG and Concord will form a fully integrated global music company spanning music publishing, recorded music, theatrical rights, and digital distribution. This increased scale will enable deeper investment in creativity, next-generation technology, and world-class talent, and will preserve the entrepreneurial approach that artists, songwriters, and playwrights value.
In fast-growing markets, where music consumption continues to evolve, the unified company will be well positioned to expand its presence, deepen artist and songwriter partnerships, and capture new revenue streams across platforms and formats. It is expected to generate significant cash flow to reinvest in the business and fuel growth. This includes a mid-term ambition to achieve $1.2 billion in EBITDA, building from a pro forma EBITDA base of more than $730 million in 2026, driven through organic growth, M&A, and synergies.
“We believe this is a truly one-of-a-kind opportunity to bring together two world-class teams and rosters at the right moment, as scale in rights ownership becomes increasingly critical to long-term growth,” said Thomas Coesfeld, Chief Executive Officer of BMG and designated Chairman of the combined company. “This transaction accelerates our successful BMGNext strategy by enabling a more ambitious and sustained approach to investing in artists and songwriters, as well as in rights, technology, AI tools, and the talent shaping the industry. As one unified business, we will further deepen our position as a preferred global partner to artists, songwriters, and platforms, combining scale with the agility and independence they value. We look forward to this next chapter and to the opportunities it creates for artists, songwriters, and partners.”
"We are excited to begin working together to build something truly exceptional," said Bob Valentine, Chief Executive Officer of Concord and designated CEO of the combined company. “Both companies were founded to support great artistry and with a deep sense of responsibility to the performers, songwriters, and playwrights we serve. We share a philosophy grounded in artist development, strategic long-term management of IP, and operational discipline. Our greater scale will allow us to invest more in creative talent, global reach, accretive acquisition opportunities, and technology, while preserving the nimble, entrepreneurial spirit that artists and songwriters value most. This is not about replicating the major label model; it’s about using scale to strengthen independence. Together, we will build a company that gives artists more reach and more flexibility – all designed to support their distinct visions.”
Collectively, the companies have invested billions of dollars in music rights and built one of the most diverse and culturally significant rosters in the industry, spanning artists, songwriters, and works from Jelly Roll, Paul Simon, Lainey Wilson, will.i.am, Jason Aldean, Tina Turner, Diane Warren, and Jean-Michel Jarre, to Creedence Clearwater Revival, Daddy Yankee, Denzel Curry, Hamilton, Phil Collins, R.E.M., and The Sound of Music.
Both businesses have delivered strong financial performance, with significant EBITDA growth and consistent cash generation in recent years. Since 2021, as part of its Boost investments program, BMG has invested more than $1.5 billion in music rights acquisitions and an equal amount in signings, licenses, and technology. BMG has doubled its operating EBITDA and delivered best-in-class profitability under its BMG Next strategy. Concord brings a similarly disciplined approach, investing more than $3 billion since 2020 across publishing, recorded music, theatrical rights, and distribution, and supporting more than 125,000 artists and songwriters around the world.
The Combined Company
Upon closing, Valentine will serve as CEO of the combined company, with Coesfeld serving as Chairman. As previously announced, Coesfeld will assume the role of CEO of Bertelsmann, effective January 1, 2027. A joint management team drawn from both companies will lead the business. The newly formed company's global headquarters will be in Nashville, with Berlin serving as its European headquarters. Its publishing division will be named BMG Publishing, and its recorded music division will be called Concord Records.
The combined company will be owned approximately 67% by Bertelsmann and approximately 33% by affiliates of Great Mountain Partners. Affiliates of Great Mountain Partners will also receive a one-time cash payment of $1.16 billion. Bertelsmann will continue to support BMG’s growth trajectory in the dynamic and fast-growing global music market.
The transaction is subject to customary closing conditions including regulatory approvals and is expected to close in the second half of 2026. Terms of the transaction were not disclosed.
Davis Polk & Wardwell LLP is serving as legal counsel to BMG. J.P. Morgan is serving as financial advisor to Concord and Latham and Watkins LLP and Reed Smith LLP are serving as legal counsel. Alston & Bird LLP is advising Great Mountain Partners.
About BMG
Founded in 2008, BMG reimagined the relationship between music companies, songwriters, and artists by offering fairer contracts, greater creative freedom, and unparalleled transparency in royalties and licensing. Now the fourth-largest music company in the world, BMG combines human creativity with cutting-edge technology to connect music with global audiences. With 16 offices across 13 key markets, BMG represents more than three million songs and recordings, including some of the most iconic catalogs and works from leading artists and songwriters, including will.i.am, Jean-Michel Jarre, Tina Turner, Jason Aldean, Jelly Roll, Paul Simon, and many more. BMG is wholly owned and privately held by the international media, services, and education company Bertelsmann.
About Concord
Concordis the world’s leading independent music company. The Company supports more than 125,000 artists and songwriters whose works are licensed, marketed, and performed globally. Concord's growing catalog of 1.3 million songs, compositions, sound recordings, films, plays, and musicals is one of the most impactful and culturally relevant collections of creative rights in history.
Concord is headquartered in Nashville with additional offices in Los Angeles, New York, London, Berlin, Melbourne, and Miami.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260427537841/en/
Contacts
Media Contacts:
Kristal McKanders Dube
BMG
Kristal.mckanders@bmg.com
Kelly Voigt
Concord
kelly.voigt@concord.com
FGS Global
bmg@fgsglobal.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HTEC Research: Only One in Three Healthcare Organizations is Ready to Scale AI28.4.2026 16:22:00 EEST | Press release
AI is already embedded across healthcare and life sciences. Most organizations are deploying it, and confidence in its potential is high. Yet for many, the real challenge is only just beginning. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260428872907/en/ HTEC, a global AI‑first provider of software and hardware design and engineering services, today released new research based on a global survey of 253 C-level HLS executives across the United States, United Kingdom, Germany, Spain, Saudi Arabia, and the UAE. AI is already embedded across healthcare and life sciences. Most organizations are deploying AI, and confidence in its potential is high. Yet for many, the real challenge is only just beginning. HTEC, a global AI‑first provider of software and hardware design and engineering services, today released new research based on a global survey of 253 C-level HLS executives across the United States, United Kingdom, Germany,
JPMorganChase Named First-Ever Global Banking Partner of the Olympic Games28.4.2026 16:00:00 EEST | Press release
The International Olympic Committee (IOC) and JPMorganChase today announced a landmark Worldwide Olympic Partnership, making JPMorganChase the first Global Banking Partner in Olympic history. The partnership includes the Los Angeles 2028 Olympic and Paralympic Games (LA28 Games) and the French Alps 2030 Olympic and Paralympic Winter Games. The firm has also reached an agreement with LA28 to become the Official Bank of Team USA and LA28, and a Founding Partner of the LA28 Games. The partnership reflects a shared commitment to ambition and excellence, and places athletes and communities at its core. Kirsty Coventry, President of the IOC, commented: “JPMorganChase is the first Global Partner from the banking sector in Olympic history, and we are proud to welcome them to the Worldwide Olympic Partner programme. This partnership reflects our shared values of ambition, excellence and will support the Olympic Movement and sport around the world. JPMorganChase’s global reach and expertise will
BlueSnap, Powered by Payroc, Launches Local Acquiring in New Zealand to Boost Approval Rates and Reduce Cross-Border Costs28.4.2026 16:00:00 EEST | Press release
BlueSnap, powered by Payroc, today announced the availability of local acquiring in New Zealand, expanding its global payment orchestration capabilities and enabling businesses to process transactions domestically. Local acquiring allows businesses with a legal entity in New Zealand to process payments through domestic acquiring banks rather than routing transactions cross-border. This helps increase authorization rates, reduce payment failures, and lower transaction costs, critical factors for businesses selling into the region. Why Local Acquiring in New Zealand Matters For B2B and B2C businesses operating globally, cross-border payments often lead to higher fees and lower approval rates. Building local acquiring infrastructure independently requires managing multiple bank relationships, compliance, and integrations, making it costly and complex. BlueSnap simplifies this by providing local acquiring through a single platform, allowing businesses with a legal entity in New Zealand to
Vensica Medical Receives FDA IND Clearance to Initiate Phase 2 Study of ViXe, Its Needle-Free Xeomin ® Delivery System for Overactive Bladder28.4.2026 15:42:00 EEST | Press release
Vensica Medical, a clinical-stage company developing needle-free therapeutic delivery solutions for urologic diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application to initiate a Phase 2 clinical trial of ViXe. The study will evaluate the Vibe® ultrasound-based, needle-free drug delivery system in combination with Xeomin® (incobotulinumtoxinA) for the treatment of overactive bladder (OAB). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414145279/en/ Avner Geva, Cofounder, CEO (left), and Avi Eftel, Cofounder, CTO (right) Overactive bladder affects an estimated 33 million adults in the United States and is characterized by urinary urgency, frequency, and incontinence. While intravesical botulinum toxin injection is an established second-line treatment, the invasive procedure limits patient access and acceptance. The ViXe program is desi
Printing the Future of Oncology: CTIBIOTECH Invests €3M and Secures €1.25M from France 2030 to Revolutionize Personalized Cancer Care28.4.2026 15:28:00 EEST | Press release
CTIBIOTECH Announces the CTIONCOTEST ™ Project to Revolutionize Cancer Research with 3D Bioprinted Microtumors, Backed by France 2030 and Bpifrance This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260428242352/en/ The CTIONCOTEST™ platform by CTIBIOTECH is an innovative 3D bioprinting technology that revolutionizes preclinical cancer research . It provides an automated, industrial-scale process to produce high-throughput, patient-specific human "microtumors" directly from primary tumor cells . Designed to tackle the 95% clinical failure rate of new cancer drugs, it faithfully replicates the complex tumor microenvironment, including critical hypoxic and necrotic zones . Targeting high-mortality breast, colon, and pancreatic cancers, the platform features three complexity levels: standard (cancer cells), intermediate (+fibroblasts), and advanced (+immune/endothelial cells) . A key breakthrough is its record cellular viability of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom